Quarterly report · Q3
6095.TEDINET S100OXHE
Period2021-10-01 → 2022-06-30
Filed2022-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 36
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥6.4bn | 2021-10-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥7.4bn | 2020-10-01 → 2021-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.5bn | 2020-10-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥907m | 2021-10-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.8bn | 2020-10-01 → 2021-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥943m | 2021-10-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥1.4bn | 2020-10-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥655m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2020-10-01 → 2021-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥943m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥651m | 2021-10-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥969m | 2020-10-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥9.2bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥8.5bn | at 2021-09-30 | Cons. | Assets |
| Total assets | ¥8.0bn | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.5bn | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.6bn | at 2021-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥7.7bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥7.0bn | at 2021-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.6bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.5bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.7bn | at 2021-09-30 | Cons. | Cash and deposits |
| EPS (basic) | ¥30.33 | 2021-10-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.59 | 2022-04-01 → 2022-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥60.07 | 2020-10-01 → 2021-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥43.82 | 2020-10-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥8.02 | 2021-04-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥28.76 | 2021-10-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.25 | 2020-10-01 → 2021-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥41.12 | 2020-10-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 80.6% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.5% | at 2021-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 78.8% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-10-01 → 2022-06-30 | −¥12m |
| Reconciling Itemsreconciling | segment profit | 2021-10-01 → 2022-06-30 | −¥518m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥4.9bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥8m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥1.3bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2021-10-01 → 2022-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥4m |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2021-10-01 → 2022-06-30 | ¥100m |
| —segment total | revenue | 2021-10-01 → 2022-06-30 | ¥6.5bn |
| —segment total | revenue external | 2021-10-01 → 2022-06-30 | ¥6.4bn |
| —segment total | revenue intersegment | 2021-10-01 → 2022-06-30 | ¥12m |
| —segment total | segment profit | 2021-10-01 → 2022-06-30 | ¥1.4bn |
| Reconciling Itemsreconciling | revenue | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | revenue intersegment | 2020-10-01 → 2021-06-30 | −¥6m |
| Reconciling Itemsreconciling | segment profit | 2020-10-01 → 2021-06-30 | −¥357m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥4.3bn |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥5m |
| jpcrp040300-q3r_E30650-000Doctor Plat Formreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥1.5bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue external | 2020-10-01 → 2021-06-30 | ¥1.2bn |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥396,000 |
| jpcrp040300-q3r_E30650-000Healthcare Solutionreportable segment | segment profit | 2020-10-01 → 2021-06-30 | ¥196m |
| —segment total | revenue | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue external | 2020-10-01 → 2021-06-30 | ¥5.5bn |
| —segment total | revenue intersegment | 2020-10-01 → 2021-06-30 | ¥6m |
| —segment total | segment profit | 2020-10-01 → 2021-06-30 | ¥1.7bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 329
| Item | Context | Value | Unit |
|---|---|---|---|
| Other cl | Prior1YearInstant | 323912000 | JPY |
| Other cl | CurrentQuarterInstant | 209613000 | JPY |
| Current liabilities | Prior1YearInstant | 1336565000 | JPY |
| Current liabilities | CurrentQuarterInstant | 1333425000 | JPY |
| Long term loans payable | Prior1YearInstant | 80184000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 38082000 | JPY |
| Asset retirement obligations ncl | Prior1YearInstant | 78815000 | JPY |
| Asset retirement obligations ncl | CurrentQuarterInstant | 79046000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 57219000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | 49212000 | JPY |
| Other ncl | Prior1YearInstant | 4766000 | JPY |
| Other ncl | CurrentQuarterInstant | 3597000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 220986000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 169938000 | JPY |
| Liabilities | Prior1YearInstant | 1557551000 | JPY |
| Liabilities | CurrentQuarterInstant | 1503364000 | JPY |
| Capital stock | Prior1YearInstant | 2028537000 | JPY |
| Capital stock | CurrentQuarterInstant | 2050169000 | JPY |
| Capital surplus | Prior1YearInstant | 2245584000 | JPY |
| Capital surplus | CurrentQuarterInstant | 2267215000 | JPY |
| Retained earnings | Prior1YearInstant | 2431410000 | JPY |
| Retained earnings | CurrentQuarterInstant | 3076158000 | JPY |
| Treasury stock | Prior1YearInstant | -576000 | JPY |
| Treasury stock | CurrentQuarterInstant | -576000 | JPY |
| Shareholders equity | Prior1YearInstant | 6704955000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 7392965000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -7036000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -11028000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -7036000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -11028000 | JPY |
| Subscription rights to shares | Prior1YearInstant | 9634000 | JPY |
| Subscription rights to shares | CurrentQuarterInstant | 9579000 | JPY |
| Non controlling interests | Prior1YearInstant | 273223000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 263221000 | JPY |
| Net assets | Prior1YearInstant | 6980777000 | JPY |
| Net assets | CurrentQuarterInstant | 7654738000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 8538329000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 9158103000 | JPY |
| Net sales | Prior1YTDDuration | 5503206000 | JPY |
| Net sales | CurrentYTDDuration | 6443320000 | JPY |
| Cost of sales | Prior1YTDDuration | 1862817000 | JPY |
| Cost of sales | CurrentYTDDuration | 2629083000 | JPY |
| Gross profit | Prior1YTDDuration | 3640389000 | JPY |
| Gross profit | CurrentYTDDuration | 3814236000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 2264838000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 2906831000 | JPY |
| Operating income | Prior1YTDDuration | 1375550000 | JPY |
| Operating income | CurrentYTDDuration | 907405000 | JPY |
| Interest income noi | Prior1YTDDuration | 171000 | JPY |
| Interest income noi | CurrentYTDDuration | 154000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |